Budesonide Foam for Ulcerative Colitis Patients Experiencing Inadequate Response to Biological Therapy

BACKGROUND: In recent years, a plethora of therapeutic agents for ulcerative colitis (UC), especially novel biologics (Bio), have become available. Although it is now possible to use biological drugs, there should be no need for frequently changing medications. To avoid first-pass metabolism in the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Med Sci Monit
Autors principals: Shibuya, Tomoyoshi, Nomura, Kei, Okahara, Koki, Haga, Keiichi, Nomura, Osamu, Murakami, Takashi, Uchida, Shino, Kodani, Tomohiro, Ishikawa, Dai, Sakamoto, Naoto, Ogihara, Tatsuo, Osada, Taro, Nagahara, Akihito
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2019
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6939661/
https://ncbi.nlm.nih.gov/pubmed/31865359
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.918562
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars